Epocal Inc.

Epocal Inc. (Epocal) is a medical device manufacturing company principally engaged in the design, development and marketing of diagnostic products for the in-vitro diagnostic markets. The company develops point-of-care blood diagnostic systems consisting of biosensors and wireless card readers that have wireless connectivity to a PDA analyzer which delivers lab quality results. Its products are developed using its patented FlexCard technology and are used in hospitals for centralized data management which is also used for hematology, homeostasis and immuno-assay tests and delivers lab quality results. Recently, the company received U.S. Food and Drug Administration (FDA) authorization to market its new glucose test on the epoc Blood Analysis System. Epocal is headquartered in Ontario, Canada.

In 2010, Epocal entered into an agreement with Inverness Medical Innovations, Inc. to distribute its epoc Blood Analysis System for blood gas and electrolyte testing.

Street: 
2060 Walkley Road.
City: 
Ottawa
Postcode: 
K1G 3P5
Federal State : 
Canada
WebSite: 
www.epocal.com
Fax: 
1-613-7386195

Company Index Score

Current Index Score Historical Index Score
  • Epocal Inc. currently scores 50 % in the index.
  • Epocal Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Epocal Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets